drugset / Trial / NCT00839891
A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers
RandomizedParallel-groupQuadruple-blind
Summary
* Determine whether VI-0521 has an effect on the electrical activity of the heart in healthy subjects. * Find out how much VI-0521 is in the blood and any potential side effects on ECG's of healthy subjects after taking the study drugs.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | VI-0521 | Unknown | 7.5 mg | — |
| Comparator | VI-0521 | Unknown | 22.5 mg | — |